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Cancer cell mitochondria represent an attractive target for oncological treatment as they
have unique hallmarks that differ from their healthy counterparts, as the presence of a
stronger membrane potential that can be exploited to specifically accumulate cytotoxic
cationic molecules. Here, we explore the selective cytotoxic effect of 10-N-nonyl acridine
orange (NAO) on human lung carcinoma H520 cells and compare them with healthy
human lung primary fibroblasts. NAO is a lipophilic and positively charged molecule that
promotes mitochondrial membrane adhesion that eventually leads to apoptosis when
incubated at high micromolar concentration. We found an enhanced cytotoxicity of NAO
in H520 cancer cells. By means Fluorescence lifetime imaging microscopy (FLIM) we
also confirmed the formation of H-dimeric aggregates originating from opposing adjacent
membranes that interfere with the mitochondrial membrane structure. Based on our
results, we suggest the mitochondrial membrane as a potential target in cancer therapy
to mechanically control the cell proliferation of cancer cells.
Keywords: NAO, mitochondrial targeting, membrane adhesion, cancer therapy, NSCLC cells, FLIM, phasor
analysis
INTRODUCTION
Cancer remains one of the most common causes of death worldwide. In particular, lung cancer is
usually detected at later stages of development (1). Additionally, the appearance of drug resistance
during the course of treatment often leads to unsatisfying outcomes and a poor prognosis of
patients (2) limited to a 5 years survival rate (3).
Traditional chemotherapeutics interfere with replication or cell division to prevent cell growth,
increase cell death and restrict the spreading of the cancer (4). Side effects of traditional cancer
treatments as surgery, chemotherapy or radiation therapy are significant as many healthy cells
are killed during the treatment, due to the lack of target specificity. With the aim to specifically
target only cancer cells, a new generation of cancer treatment has been developed recently known
as the targeted cancer therapy (5), where pharmacological agents (monoclonal antibodies, small
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molecule inhibitors or immunotoxins) that interfere with specific
signaling proteins involved in tumor genesis are used (5).
For instance, the epidermal growth factor receptor (EGFR)
represents currently a major target in lung cancer therapy.
However, the development of acquired resistance is now
well recognized for promising monoclonal antibodies acting
as EGFR inhibitors (6, 7). A new promising strategy for
cancer therapy focuses on mitochondria as they participate as
key regulators in the apoptosis. Mitochondria of cancer cells
exhibit unique and multiple characteristics that differ from
their healthy counterparts. Among them, a stronger (more
negative) mitochondrial membrane potential (8) that suggests
an underlying increased accumulation of cytotoxic cationic
molecules within cancer cells (9–13). The compounds directed
to mitochondria and able to interfere with the mitochondrial
function, become promising antitumor agents (4, 14–16) and
may represent a more selective and effective option for therapy.
As a proof-of-concept, we explore here the selective cytotoxic
effect of the compound 10-N-nonyl acridine orange (NAO)
on human lung carcinoma H520 cells. NAO is a lipophilic
fluorescent molecule used as a mitochondrial marker that stains
the inner mitochondrial membrane (IMM) (11). NAO was
previously shown to be cytotoxic when present at low milimolar
concentrations (17) and we have recently shown the underlying
molecular mechanisms of this cytotoxicity. The formation H-
aggregates of NAOmolecules originating from opposing adjacent
membranes elicits interbilayer adhesion of mitochondria and
interferes withmitochondrial dynamics leading to apoptosis (18).
We demonstrate the specific cytotoxic activity of NAO
in H520 human lung carcinoma cells exposed at NAO
concentration that are not harmful for healthy human lung
primary fibroblast (HLPF). H520 cells represent a paradigmatic
non-small cell lung cancer (NSCLC) cells and they have proven
to be a powerful tool for cancer research. We also identify by
means of Fluorescence life time imaging microscopy (FLIM) the
presence of long-lifetime H-dimers of NAO, generally formed
when present at high local concentration.
RESULTS
NAO Exhibits a Strong Cytotoxic Activity in
H520 Cancer Cells
To determine the enhanced cytotoxicity of NAO in cancer cells,
H520 cancer cells and healthy HLPF (control) were exposed
for 60min to increasing amounts of NAO (1 nM−1mM) and
cell viability was determined by the MTT assay (Figure 1). The
viability of H520 starts to be compromised in the presence of
0.1µM and cells were severely killed in the presence of NAO
at concentrations up to 1mM. The cell viability of HLPF is
not affected until the presence of 10µM of NAO and shows
a survival of approximately 30% in the presence of 1mM of
NAO. The calculated CC50 values vary 25 fold with ≈15µM for
H520 and ≈385µM for HLPF (Figure 1). Alternative cationic
dyes 1,1′-Dioctadecyl-3,3,3′,3′-Tetramethylindotricarbocyanine
Iodide (DiR) and Tetramethyl rhodamine methyl ester (TMRM)
were also tested for cell toxicity. DiR is long-chain lipophilic
FIGURE 1 | Cell viability of HLPF and H520 cells upon NAO incubation. The
experimental data were satisfactorily fitted by a classical sigmoidal curve that
is obtained with the Hill model (19). The Hill model is based on the equation






)H , which describes the cytotoxic effect CHill
obtained at a given concentration C; where CC50 is the relative 50% cytotoxic
concentration reducing cell viability by 50%, H is the Hill exponent, C∞ is the
maximum cytotoxicity and C0 is the viability in the absence of NAO. Inset:
Chemical structure of 10-N-nonyl acridine orange (NAO).
carbocyanine dye (20) and TMRM is a dye used for monitoring
the mitocondrial membrane potential (21). The obtained CC50
values of these dyes vary from ≈3 × 102 µM for H520 cells to >
mM for HLPF cells (Figure S1). The toxicity of DiR and TMRM
were only observed in cancer cells and at one order of magnitude
higher than observed for NAO. Hereinafter we focus on NAO
because of its enhanced cytotoxicity.
Next, we measured the conformational arrangement of NAO
in H520 and HLPF cells by means of fluorescence confocal
microscopy. The incubation with high concentration of NAO
leads to cell death accompanied with a green-to-red emission
shift where the maximum emission wavelength at λem =
525 nm shifts to 640 nm due to the formation of supramolecular
aggregates (22) that result from the pi-pi interactions between
the stacked acridine orange moieties (23, 24). In agreement with
the previous literature and our own observations (11, 18) the
incubation of NAO at low nM concentrations merely stains
the mitochondrial network of both H520 and HLPF cells, but
does not exhibit visual signs of cytotoxicity (Figure S2). The
low red shift of NAO observed in HPLF cells did not induced
apoptosis, even for long incubation times (up to 48 h). In
contrast, at high µM concentrations, the mitochondria of H520
immediately stained and cells entered apoptosis that can be
appreciated by the global morphological changes as membrane
blebbing or cell shrinkage (Figure 2). As previously shown, this
morphological remodeling of the mitochondrial network into
spherical liposomal appearance is simultaneously accompanied
by the red shift of NAO and a direct consequence of the formation
of supramolecular NAO zippers among adjacent mitochondrial
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FIGURE 2 | Interbilayer NAO dimers elicit cytotoxicity in HLPF and H520 cells. Confocal fluorescence micrographs (green channel, λexc = 488 nm and red channel,
λexc = 561nm) of HLPF and H520 mitochondria in the presence of 5µM of NAO. NAO induces apoptosis and the spectral shift from green to red, indicative for the
formation of interbilayer NAO dimers (See main text for details). Scale bars are 10µm.
membranes (Figure 2) (18). At high concentrations, also HLPF
control cells were compromised and both the red shift and
the morphological changes of mitochondria were appreciated at
longer incubation times (Figure 2).
The Cytotoxic Effect of NAO in H520 and
HLPF Cells Originates From the
Supramolecular Assembly of NAO Dimers
in Mitochondrial Membranes
Time-resolved fluorescence imaging allowed us to characterize
the molecular basis of the NAO induced cytotoxicity.
Within eukaryotic cells and depending on the administered
concentration of NAO, three spectroscopic molecular species
of NAO can be observed in the mitochondrial membranes.
The molecular species are characterized by different excited-
state lifetimes of 0.2 ns (very short excited-state species),
2.0 ns (intermediate excited-state species), and 10 ns (long
excited-state species). The very short species corresponds to the
self-quenched clustered form of NAO, the intermediate species
to the monomeric form and the long excited-state species to the
red-shifted dimeric form (18). Note that, the 10-ns lifetime NAO
species was only detected in the red channel #1; whereas the
2.0-ns and 0.2-ns NAO species were detected in both emission
channels, but mainly in the green channel #2.
Two-photon FLIM-phasor images of a representative group
of H520 and HLPF cells incubated for 60min with 10 nM NAO
show the presence and the quantification of the three species. All
three lifetimes (10, 2.0, and 0.2 ns) lie on the universal phasor
circle (black cursors) (25). In the low nM concentration regime
(Figure 3), the phasor clusters determined for the channel #1
and #2 FLIM images correspond to nearly pure NAO monomer
molecules for both cell lines. Note that the lower accumulation
of NAO in HLPF cells leads the phasor cluster of the channel #1
to overlap the phasor cluster corresponding to autofluorescence.
When both H520 and HLPF cells are incubated for short times
(up to 60min) with NAO at high µM concentrations the phasor
cluster correspond to a mixture of the three species as indicated
by the localization of the phasor cluster inside the three species
triangle in channel #1 and #2 (Figure 4).
Though the population of NAO (2.0 ns) monomers species
predominates (blue cursor and blue color in the phasor color
map) in the early stages of the interaction, the (10 ns) long
excited-state NAO species becomes predominant (in red channel
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FIGURE 3 | Spatial distribution of NAO molecular species in HLPF and H520 cells. Basal XY sections of representative groups of cells treated with 10 nM NAO for
60min and their corresponding phasor plots showing regions enriched in intermediate-lifetime NAO monomers (blue cursor; as detected in channel #1 and channel
#2). Gray cursors show cell autofluorescence. Black cursors on the phasor plot represent 100% pure NAO species: NAO antiparallel H-dimers (τ = 10 ns),
monomeric NAO (τ = 2.0 ns), and self-quenched NAO aggregates (τ = 0.2 ns). Black dashed lines joining the three pure species phasors form a triangle that would
contain phasors from all possible intensity-weighted combinations of the three NAO molecular species. Pixels corresponding to the cluster of phasors enclosed by the
colored circles are highlighted on the intensity image using the same color. λexc = 850 nm, red channel (#1) FF01 685/40, green channel (#2) FF02 520/35, dichroic
filter FF560-Di01 (Semrock, Germany), 1.2 ms/pixel.
#1; red cursor and red color in the phasor color map) and the
(0.2 ns) self-quenched population species emerges (blue channel
#2; light blue cursor and light blue color in the phasor color
map) during the progress of NAO accumulation. As previously
shown (18) the formation of red-shifted NAO-dimers indicates
the supramolecular assembly of molecular zippers between
stacked NAO from opposing bilayers producing membrane
remodeling in mitochondria that compromise the survival of the
cell (Figure 2). This molecular mechanism by which the widely
used mitochondrial dye NAO exhibits cytotoxicity is enhanced
in NSCLC H520 cells as compared to HLPF cells (Figure 1).
DISCUSSION
The primary function of mitochondria is to provide the
chemical energy to eukaryotic cells in the form of adenosine
triphosphate (ATP). As this function is essential for cell viability,
mitochondria are being explored as a promising target for
therapeutic purposes. The fact that mitochondria of cancer cells
exhibit characteristics different from healthy cells, allow the
design of new strategies focusing on enhanced selectivity and
reduced acquired drug resistance. Beyond its well-established
role in cellular energetics, mitochondria are key controllers
of apoptosis (26). Pro-apoptotic factors, such as cytochrome
c, reside in the mitochondrial intermembrane space and are
liberated to the cytoplasm during apoptosis. This activates
caspase proteases and the subsequent cleavage of structural
and regulatory proteins in the cytoplasm and the nucleus
(27). New cancer therapies aim to specifically induce apoptosis
through pharmacological agents acting on mitochondria and
promoting mitochondrial failure or damage (14). Cancer cells
exhibit a stronger (more negative) mitochondrial membrane
potential, a particular feature that opens the way to control of
cell proliferation and survival by means of regulation of the
mechanical properties of mitochondrial membranes. This strong
membrane potential of mitochondria allows the accumulation
of cationic lipophilic molecules within the mitochondrial matrix
at non-effective concentrations of normal cells. This rational
leads to the design and synthesis of mitochondrial dyes (18, 28),
such as NAO, a lipophilic and positively charged fluorescent
dye able to diffuse spontaneously into membrane environments
(17). The incubation with concentrations in the µM range of
NAO induces cytotoxicity (26). In contrast to other cationic
dyes that accumulate in mitochondria (DiR and TMRM), it
is only required a lower concentration of NAO to produce
fatal consequences for cell viability (17). The ability of NAO to
form supramolecular stacks is provided by the acridine orange
moiety (23), but the presence of the aliphatic chain enhances
the partitioning of NAO into the membrane and promotes
its cytotoxic mechanism (18). NAO dimers from opposite
membranes trigger their adhesion and cause severe mechanical
alterations of mitochondrial dynamics, promotingmitochondrial
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FIGURE 4 | Spatial distribution of H-dimers in HLPF and H520 cells. Basal XY sections of representative groups of cells treated with 5µM NAO at different times.
Their corresponding phasor plots show regions enriched in long-lifetime NAO antiparallel H-dimers (red cursor; as detected in channel #1), intermediate-lifetime NAO
monomers (blue cursor; as detected in channel #2) and the short-lifetime NAO self-quenched clusters (light blue cursor; as detected in channel #2). Gray cursors
show cell autofluorescence. Black cursors on the phasor plot represent again 100% pure NAO species: NAO antiparallel H-dimers (τ = 10 ns), monomeric NAO (τ =
2.0 ns), and self-quenched NAO aggregates (τ = 0.2 ns). Black dashed lines joining the three pure species phasors form a triangle that would contain phasors from all
possible intensity-weighted combinations of the three NAO molecular species. Pixels corresponding to the cluster of phasors enclosed by the colored circles are
highlighted on the intensity image using the same color. λexc = 850 nm, red channel (#1) FF01 685/40, green channel (#2) FF02 520/35, dichroic filter FF560-Di01
(Semrock, Germany), 1.2 ms/pixel.
membrane remodeling. As a result, mitochondria lose their
characteristic ultrastructure and form double-membrane vesicles
comprising the outer and inner membranes (18, 29). The
stronger cytotoxicity of NAO on carcinoma H520 cells is
compatible with a higher accumulation of NAO into cancer
mitochondria producing cell death at lower effective dose
compared to non-cancerous cells (Figure 1). We also show a
similar accumulating effect in cancer cells for the other cationic
dyes tested (Figure S1).
Note that the mitochondrial membrane potential established









where E is the membrane potential, [NAO]o is the cytosolic
concentration of NAO, [NAO]i is the mitochondrial
concentration of NAO, R is the ideal gas constant, T is the
temperature, z is the charge of the dye and F is the Faraday’s
constant. Thus, a stronger (e.g., two-fold) mitochondrial
potential in cancer cells (21, 29) will result in a ten-fold
accumulation of the cationic probe within the cancer cell
(Figure 5). Additional factors as an increased mitochondrial
mass (30) or a different composition of negatively charged lipids
as cardiolipin (31) can also control the enhanced selectivity of
lipophilic and positively charged molecules. To reliably ground
the physico-chemical mechanisms that drive the enhanced NAO
accumulation in cancer mitochondria the direct measurement of
both the membrane potential and the absolute concentration of
NAO in living cells is required (32).
Anticancer drugs that directly target mitochondria might
have the potential to bypass the drug-resistance acquired by
cancer cells during chemotherapy treatment. In particular, novel
targeted therapies must be based on physical mechanisms at
the mesoscale, the adhesion of mitochondrial membranes in
our case, instead of interfering with the molecular biochemical
signals that can be easily reprogrammed by the cell. The
mechanical targeting proposed here may provide a unique tool
to circumvent the acquired survival mechanisms and may be
effective in otherwise resistant forms of cancer. The proof-of-
concept still needs to explore the therapeutic window with more
NSCLC cell lines including those that acquired resistance during
chemotherapy and more important with other kind of healthy
cells, in particular for those more susceptible to mitochondrial
functioning. Also, in vivo experiments with murine models are
essential for a complete validation of the approach.
MATERIALS AND METHODS
Chemicals
10-N-nonyl acridine orange (NAO), 1,1′-Dioctadecyl-
3,3,3′,3′-Tetramethylindotricarbocyanine Iodide (DiR) and
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FIGURE 5 | Strategy focusing on enhanced selectivity for cancer cells. The negative membrane potential of healthy mitochondria (HLPF cells) enables lipophilic and
positively charged molecules (NAO) to accumulate in the inner membrane. A more negative membrane potential in cancer cells (H520 cells) triggers an enhanced
accumulation of NAO leading to cytotoxicity.
Tetramethyl rhodamine methyl ester (TMRM) were supplied
by Thermofisher. Ultrapure water was produced from a Milli-Q
unit (Millipore, conductivity below 18 M cm).
Cell Culture
The cell line of human lung primary fibroblast (HLPF) was
provided by Pr. Alejandro Sweet-Cordero from University of
California San Francisco (UCSF) under the terms of a Material
Transfer Agreement; and no ethical approvals were required
for their use in this study as per local legislation and national
guidelines. HLPF cells were maintained in DMEM + GlutaMax-
I, supplemented with 10% fetal bovine serum (FBS), penicillin
(50 U/mL) and streptomycin (50µg/mL) (Thermofisher) and
human lung tumor cells (H520) were maintained in RPMI-
1640 medium, supplemented with 10% fetal bovine serum
(FBS), penicillin (50 U/mL) and streptomycin (50µg/mL)
(Thermofisher). All cells were maintained in a humidified
incubator at 37◦C and 5% CO2 atmosphere (Forma Steri-
Cycle Themofisher; 5% CO2). Cells were plated in 75 cm2
flasks (Thermofisher) and were passaged when reaching 95%
confluence, by gentle trypsinization 0.05% trypsin/0.53mM
EDTA; Invitrogen Life Technologies).
Cell Viability
Cell viability was evaluated by using the
methylthiazoletetrazolium assay (MTT; Sigma-Aldrich). All
experimental conditions were performed in quadruplicate. Cells
were seeded in 96-well flat-bottom plates at 5,000 cells/well.
After 24 h, the medium was replaced with 100 µl medium
with different concentrations of NAO, DiR and TMRM (1
nM−1mM). After 60, 90, 120, and 150min, each well was
replaced with 100 µl MTT solution (5 mg/ml). After 2 h
incubation at 37◦C, 5% CO2, each well was replaced with 100
µl DMSO (Sigma-Aldrich). The cell viability was determined by
measuring the absorbance at 570 nm using a spectrophotometer
(MultiskanTM FC, Thermofisher). Results are presented as the
percentage survival in relation to untreated control cells.
Confocal Microcopy
Confocal microscopy images of cells were collected at 37◦C with
a Nikon Ti-E inverted microscope equipped with a Nikon C2
confocal scanning confocal module, 488 and 561 nm continuous
lasers, emission bandpass filters, and a Nikon Plan Apo 100 ×
NA 1.45 oil immersion objective. Both H520 and HLPF cells were
seeded at 3 × 104 cells per cm2 in a four-chamber Lab-Tek R©
slide (Thermofisher) and incubated with complete DMEM for
HLPF cells and RPMI for H520 cells, both for 24 h at 37◦C. Prior
to confocal fluorescence imaging, cells were supplemented with
NAO (5 nM or 5µM).
Two-Photon Fluorescence Lifetime
Imaging
Two-photon, two-color (red channel #1 and green channel
#2) fluorescence-lifetime imaging (2P-FLIM) of XY sections of
cells was carried out on a MicroTime200 system (PicoQuant,
Germany) equipped with a mode-locked, femtosecond-pulsed
Ti:Sapphire laser (Mai-Tai, Spectra Physics, CA) operating at a
repetition rate of 80 MHz, horizontally polarized, and tuned to
850 nm; an Olympus IX71 inverted microscope mounted with
a 60X water-immersion objective NA1.2; a piezo XY-scanning
table and two single-photon counting avalanche diodes (τ -
SPAD, PicoQuant, Germany), and a PicoHarp 300 PC-board
(PicoQuant, Germany), synchronized with the excitation laser
pulses using the Time-Tagged Time-Resolved (TTTR) detection
mode at 23◦C. The TTTR mode allows the recording of every
individual fluorescence photon from each pixel, together with
its timing and emission color (channel #1, channel #2). The
acquisition time per pixel accounted for 1.2ms, resulting in an
image overall acquisition time of 180 s. Once the acquisition
of the image was finished, all the detected photons per pixel
were used to build steady-state fluorescence intensity images
or to produce Fast FLIM (Figure S3) and FLIM phasor images
using the ps-temporal resolution of the system, SymphoTime
64 software (Fast FLIM; PicoQuant, Germany), and SimFCS
software (Phasor Analysis) developed at the Laboratory of
Fluorescence Dynamics (LFD, UC Irvine). The filters used in
this study were all from Semrock (Germany). Red channel (#1):
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FF01-685/40; green channel (#2): FF01-520/35; with a dichroic
beam splitter FF560-Di01. Although in the red channel #1 we
mostly select red NAO aggregates, a non-negligible bleed through
fromNAOmonomers may exist, particularly when the monomer
NAO population is the majority. The excitation power was lower
than 1 mW at the sample, and it was adjusted using a variable
optical attenuator LS-107AT (Lasing, S.A. Spain) to achieve
counting rates below 106 photons/s. Both H520 and HLPF cells
were seeded at 2 × 104 cells per cm2 in an 8-chamber Lab-
Tek R© slide (Thermofisher) and incubated with complete RPMI
1640 or DMEM for 24/36 h at 37◦C. Prior to FLIM imaging at
the micro-spectrometer, cells were washed with Tyrode-glucose
buffer (NaCl 145mM, KCl 4mM, MgCl2 1mM, CaCl2 1.8mM,
HEPES-Na 10mM, glucose 10mM, pH 7.4) and supplemented
with NAO (10 nM or 5µM).
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